The ecosystem between biotech and pharma has never been richer and "it's so interesting to see that symbiosis working so well."
So said James Sabry, global head of pharma partnering at Roche Holding AG, speaking to Scrip at the Swiss giant's headquarters in Basel earlier this month. He noted that "if you go back 20 or 25 years, there were only a handful of biotech companies and they were relatively small. We had big companies like Merck & Co., Inc